Profile data is unavailable for this security.
About the company
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.
- Revenue in USD (TTM)289.21m
- Net income in USD-167.83m
- Incorporated2016
- Employees1.18k
- LocationFulgent Genetics Inc4399 SANTA ANITA AVEEL MONTE 91731United StatesUSA
- Phone+1 (626) 350-0537
- Fax+1 (626) 454-1667
- Websitehttps://www.fulgentgenetics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZimVie Inc | 457.43m | -56.05m | 426.82m | 2.60k | -- | 1.04 | -- | 0.9331 | -2.12 | -14.87 | 17.33 | 15.12 | 0.3213 | 1.07 | 3.91 | 175,935.80 | -3.94 | -- | -4.56 | -- | 63.48 | 65.51 | -12.25 | -8.73 | 2.32 | -0.5562 | 0.5541 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Nevro Corp | 425.17m | -92.21m | 451.91m | 1.22k | -- | 1.53 | -- | 1.06 | -2.57 | -2.57 | 11.82 | 8.06 | 0.6868 | 1.24 | 5.37 | 349,937.40 | -14.90 | -13.64 | -17.15 | -16.68 | 68.22 | 68.54 | -21.69 | -20.67 | 4.94 | -- | 0.4191 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Orthofix Medical Inc | 746.64m | -151.40m | 487.03m | 1.63k | -- | 0.8082 | -- | 0.6523 | -4.15 | -4.15 | 20.33 | 16.11 | 1.08 | 1.62 | 7.08 | 456,940.60 | -21.88 | -8.88 | -26.68 | -10.96 | 65.13 | 72.37 | -20.28 | -9.28 | 1.20 | -16.11 | 0.1595 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Iradimed Corp | 65.56m | 17.19m | 511.07m | 148.00 | 29.88 | 7.15 | 28.46 | 7.80 | 1.35 | 1.35 | 5.15 | 5.64 | 0.738 | 1.69 | 5.14 | 442,988.50 | 19.35 | 13.16 | 22.51 | 14.58 | 76.50 | 76.55 | 26.22 | 21.46 | 3.87 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Nano-X Imaging Ltd | 9.91m | -60.78m | 524.05m | 180.00 | -- | 2.68 | -- | 52.91 | -1.08 | -1.08 | 0.1758 | 3.38 | 0.0419 | -- | 8.05 | -- | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Embecta Corp | 1.12bn | 55.30m | 595.94m | 2.20k | 10.78 | -- | 6.63 | 0.531 | 0.9598 | 0.9598 | 19.47 | -13.78 | 0.9296 | 2.57 | 19.35 | 510,181.80 | 4.58 | -- | 6.44 | -- | 66.55 | -- | 4.93 | -- | 1.75 | 1.67 | 1.94 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Fulgent Genetics Inc | 289.21m | -167.83m | 601.30m | 1.18k | -- | 0.5249 | -- | 2.08 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Jin Medical International Ltd | 19.98m | 3.25m | 623.06m | 269.00 | 178.32 | 26.20 | 174.12 | 31.19 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
| SI-Bone Inc | 138.89m | -43.34m | 628.29m | 344.00 | -- | 3.68 | -- | 4.52 | -1.13 | -1.13 | 3.62 | 4.16 | 0.716 | 1.57 | 6.52 | 403,738.40 | -22.34 | -27.88 | -25.24 | -30.94 | 78.78 | 85.03 | -31.20 | -51.09 | 8.15 | -- | 0.1756 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Atrion Corp | 169.33m | 19.41m | 678.81m | 712.00 | 35.00 | 2.79 | 19.67 | 4.01 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Silk Road Medical Inc | 177.13m | -55.74m | 682.42m | 474.00 | -- | 4.51 | -- | 3.85 | -1.44 | -1.44 | 4.56 | 3.86 | 0.6622 | 2.04 | 8.52 | 373,700.40 | -20.84 | -29.02 | -23.22 | -32.98 | 71.75 | 72.91 | -31.47 | -46.84 | 6.97 | -- | 0.3335 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Varex Imaging Corp | 877.80m | 44.60m | 686.95m | 2.30k | 25.21 | 1.21 | 8.70 | 0.7826 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Treace Medical Concepts Inc | 187.12m | -49.53m | 698.02m | 516.00 | -- | 5.05 | -- | 3.73 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Orthopediatrics Corp | 148.73m | -20.97m | 700.74m | 247.00 | -- | 1.83 | -- | 4.71 | -0.9251 | -0.9251 | 6.56 | 16.13 | 0.3433 | 0.4073 | 5.01 | 602,153.90 | -4.84 | -5.40 | -5.28 | -5.93 | 74.80 | 75.09 | -14.10 | -15.92 | 2.90 | -- | 0.026 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| BioLife Solutions Inc | 143.27m | -66.43m | 718.46m | 409.00 | -- | 2.12 | -- | 5.01 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Cytek Biosciences Inc | 193.01m | -12.15m | 779.71m | 676.00 | -- | 1.98 | -- | 4.04 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
Data as of Apr 19 2024. Currency figures normalised to Fulgent Genetics Inc's reporting currency: US Dollar USD
30.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 3.28m | 11.03% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 1.45m | 4.86% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.38m | 4.65% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 812.93k | 2.73% |
| Geode Capital Management LLCas of 31 Dec 2023 | 462.76k | 1.55% |
| Park West Asset Management LLCas of 31 Dec 2023 | 424.78k | 1.43% |
| Invesco Capital Management LLCas of 31 Dec 2023 | 368.80k | 1.24% |
| Millennium Management LLCas of 31 Dec 2023 | 364.73k | 1.23% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2023 | 275.57k | 0.93% |
| Charles Schwab Investment Management, Inc.as of 31 Dec 2023 | 267.31k | 0.90% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
